Lawsuit Overview
February 21, 2014 (Shareholders Foundation) - An investor who currently holds shares of Chindex International, Inc. (NASDAQ:CHDX) filed a lawsuit in effort to halt the proposed takeover of Chindex International, Inc. for $19.50 per share.
The plaintiff alleges that the defendants breached their fiduciary duties owed to Chindex International, Inc. (NASDAQ:CHDX stockholders arising out of the attempt to sell Chindex International, Inc. too cheaply via an unfair process.
On Feb. 17, 2014 Chindex International, Inc. (NASDAQ:CHDX) announced that it has entered into a merger agreement with a buyer consortium (the Buyer Consortium ) of an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. , and Ms. Roberta Lipson, the CEO of the Company, in a transaction having an implied equity value of approximately $369 million.
Under the terms of the merger agreement, the Buyer Consortium will acquire all of the outstanding shares of Chindex International, Inc.’s common stock for $19.50 per share in cash.
However, the plaintiff alleges that the $19.50-offer is too low and undervalues Chindex International, Inc.
Chindex International, Inc. reported that its annual Total Revenue rose from $11.440 million in 2011 to $152.44 million in 2012 and that its respective Net Income increased from $3.20 million to $4.09 million.
Shares of Chindex International, Inc. (NASDAQ:CHDX) grew from $3.64 per share in March 2009 to as high as $18.87 per share in August 2013.
On February 21, 2014, NASDAQ:CHDX shares closed at $19.25 per share.